Gnp Calamine Topical Suspension Lotion
NDC Package 24385-413-96

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Gnp Calamine Topical Suspension (calamine 8% and zinc oxide 8%) lotions is a medication used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). This formulation utilizes a lotion delivery system. Marketed by Amerisource Bergen, this product is identified by NDC 24385-413 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
24385-413-96
Package Description
177 mL in 1 BOTTLE, PLASTIC
Product Code
24385-413
11-Digit Billing Format
24385041396
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
177 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Gnp Calamine Topical Suspension
Non-Proprietary Name
Calamine 8% And Zinc Oxide 8%
Substance Name
Zinc Oxide
Dosage Form
Lotion - An emulsion, liquid1 dosage form. This dosage form is generally for external application to the skin.2
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
ZINC OXIDE 160 mg/mL
Pharmacologic Class
Usage Information
This medication is used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). It works by forming a barrier on the skin to protect it from irritants/moisture.

Regulatory & Marketing

Labeler Name
Amerisource Bergen
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-01-2008
End Marketing Date
11-01-2029
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 24385-413-96 identifies a specific commercial package of 177 ml in 1 bottle, plastic of Gnp Calamine Topical Suspension, a human over the counter drug labeled by Amerisource Bergen. This lotion is formulated for topical use and contains zinc oxide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Amerisource Bergen on January 01, 2008.

What are the primary indications for this medication?

This medication is used to treat and prevent diaper rash and other minor skin irritations (e.g., burns, cuts, scrapes). It works by forming a barrier on the skin to protect it from irritants/moisture.

How is this Amerisource Bergen product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 24385041396. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 177 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
24385-413-96
11-Digit CMS (5-4-2)
24385-0413-96

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.